TY  - JOUR

T1  - Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG

JO  - Journal of Bone Oncology

UR  - http://eprints.whiterose.ac.uk/117075/

PY  - 2017/06/01

AU  - Hadji P

AU  - Aapro MS

AU  - Body J-J

AU  - Gnant M

AU  - Brandi ML

AU  - Reginster JY

AU  - Zillikens MC

AU  - Glüer C-C

AU  - de Villiers T

AU  - Baber R

AU  - Roodman GD et al

ED  - 

DO  - DOI: 10.1016/j.jbo.2017.03.001

VL  - 7

SP  - 1

EP  - 12

Y2  - 2025/10/10

ER  -